SCHEMBL6842737

SCHEMBL6842737

Cc1nn2ccc(OCCNC(=O)C(C)(C)C)cc2c1-c1nc(-c2ccccc2)c(-c2ncn[nH]2)s1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
APOBEC3A P31941 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
MAPT P10636 3/20 0.33
ALPL P05186 1/20 0.32
TP53 P04637 3/20 0.32
KDM4E B2RXH2 1/20 0.32
BRD4 O60885 1/20 0.31
SCD O00767 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
ACSS2 Q9NR19 1/20 0.31
CNR1 P21554 1/20 0.31
PIK3CG P48736 1/20 0.31
KLKB1 P03952 1/20 0.30
NR2F2 P24468 1/20 0.30
SMN1; SMN2 Q16637 2/20 0.30
HTT P42858 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6842744 0.88 MAPT (0.34) MAPTTP53KDM4EBRD4SCD
SCHEMBL953036 0.86 MAPT (0.33) MAPTTP53KDM4EBRD4SCD
SCHEMBL16937964 0.84 MAPK14 (0.34) ACSS2CNR1PIK3CGKLKB1
SCHEMBL952462 0.82 MAPK14 (0.34) ACSS2CNR1PIK3CGKLKB1
SCHEMBL16937967 0.81 ACSS2 (0.36) MAPTKDM4EALDH1A1GAAACSS2
SCHEMBL6842754 0.80 ACSS2 (0.36) MAPTKDM4EALDH1A1ACSS2CNR1
SCHEMBL951939 0.78 ACSS2 (0.37) MAPTKDM4EALDH1A1ACSS2CNR1
SCHEMBL16937972 0.76 CNR1 (0.34) KDM4EALDH1A1CNR1PIK3CGKLKB1
SCHEMBL13256711 0.76 KDM4E (0.31) KDM4EALDH1A1GAA
SCHEMBL6842755 0.75 CNR1 (0.34) KDM4EALDH1A1CNR1PIK3CGKLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090601-B2 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-07-28 US disclosed
US-20110003807-A1 Thiazole derivatives MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110003807-A1 Thiazole derivatives MTOR, RICTOR, AKT2 MEN1 794/4885KMT2A 2441/4885APOBEC3A 4838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.